PT91539A - Processo para a preparacao de novos derivados peptidicos com accao antagonista do neuropeptido y - Google Patents
Processo para a preparacao de novos derivados peptidicos com accao antagonista do neuropeptido yInfo
- Publication number
- PT91539A PT91539A PT91539A PT9153989A PT91539A PT 91539 A PT91539 A PT 91539A PT 91539 A PT91539 A PT 91539A PT 9153989 A PT9153989 A PT 9153989A PT 91539 A PT91539 A PT 91539A
- Authority
- PT
- Portugal
- Prior art keywords
- neuropeptido
- preparation
- antagonist action
- derivatives
- peptidic derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57545—Neuropeptide Y
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23759988A | 1988-08-26 | 1988-08-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
PT91539A true PT91539A (pt) | 1990-03-08 |
PT91539B PT91539B (pt) | 1995-05-04 |
Family
ID=22894403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT91539A PT91539B (pt) | 1988-08-26 | 1989-08-24 | Processo para a preparacao de novos derivados peptidicos com accao antagonista do neuropeptido y |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0355794B1 (pt) |
JP (1) | JPH02111793A (pt) |
KR (1) | KR900003203A (pt) |
CN (1) | CN1040594A (pt) |
AT (1) | ATE100466T1 (pt) |
DE (1) | DE68912453T2 (pt) |
DK (1) | DK421489A (pt) |
ES (1) | ES2061839T3 (pt) |
FI (1) | FI894007A (pt) |
HU (1) | HU204541B (pt) |
IL (1) | IL91396A0 (pt) |
NO (1) | NO893431L (pt) |
NZ (1) | NZ230385A (pt) |
PT (1) | PT91539B (pt) |
ZA (1) | ZA896374B (pt) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0668910B1 (en) * | 1991-11-06 | 1999-05-26 | Garvan Institute Of Medical Research | Human neuropeptide y-y1 receptor |
GB9213215D0 (en) * | 1992-06-20 | 1992-08-05 | Wellcome Found | Peptides |
US5516653A (en) * | 1993-12-28 | 1996-05-14 | Synaptic Pharmaceutical Corporation | DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof |
US5545549A (en) * | 1994-02-03 | 1996-08-13 | Synaptic Pharmaceutical Corporation | DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof |
US5602024A (en) | 1994-12-02 | 1997-02-11 | Synaptic Pharmaceutical Corporation | DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
US5989920A (en) | 1994-12-02 | 1999-11-23 | Synaptic Pharmaceutical Corporation | Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5 |
FR2754709B1 (fr) | 1996-10-23 | 1999-03-05 | Sanofi Sa | Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition |
US6713265B1 (en) | 1997-06-04 | 2004-03-30 | Synaptic Pharmaceutical Corporation | Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
DE602004026289D1 (de) | 2003-05-05 | 2010-05-12 | Probiodrug Ag | Glutaminylcyclase-hemmer |
WO2005049027A2 (en) | 2003-11-03 | 2005-06-02 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
CA2554809C (en) | 2004-02-05 | 2014-04-29 | Probiodrug Ag | Novel n-alkyl thiourea- and thioamide-substituted imidazolyl inhibitors of glutaminyl cyclase |
EP2089383B1 (en) | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
JP5930573B2 (ja) | 2007-03-01 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤の新規使用 |
WO2008128985A1 (en) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Thiourea derivatives as glutaminyl cyclase inhibitors |
EP2264026A4 (en) | 2008-03-06 | 2012-03-28 | Msd Kk | ALKYLAMINOPYRIDINE DERIVATIVE |
ES2548913T3 (es) | 2009-09-11 | 2015-10-21 | Probiodrug Ag | Derivados heterocíclicos como inhibidores de glutaminil ciclasa |
EP2542549B1 (en) | 2010-03-03 | 2016-05-11 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
EA022420B1 (ru) | 2010-03-10 | 2015-12-30 | Пробиодруг Аг | Гетероциклические ингибиторы глутаминилциклазы (qc, ec 2.3.2.5) |
US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
US8530670B2 (en) | 2011-03-16 | 2013-09-10 | Probiodrug Ag | Inhibitors |
EP3461819B1 (en) | 2017-09-29 | 2020-05-27 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
-
1989
- 1989-08-21 ZA ZA896374A patent/ZA896374B/xx unknown
- 1989-08-22 AT AT89115470T patent/ATE100466T1/de not_active IP Right Cessation
- 1989-08-22 JP JP1214291A patent/JPH02111793A/ja active Pending
- 1989-08-22 DE DE89115470T patent/DE68912453T2/de not_active Expired - Fee Related
- 1989-08-22 NZ NZ230385A patent/NZ230385A/en unknown
- 1989-08-22 ES ES89115470T patent/ES2061839T3/es not_active Expired - Lifetime
- 1989-08-22 EP EP89115470A patent/EP0355794B1/en not_active Expired - Lifetime
- 1989-08-23 IL IL91396A patent/IL91396A0/xx unknown
- 1989-08-24 PT PT91539A patent/PT91539B/pt not_active IP Right Cessation
- 1989-08-25 KR KR1019890012120A patent/KR900003203A/ko not_active Application Discontinuation
- 1989-08-25 CN CN89106526A patent/CN1040594A/zh active Pending
- 1989-08-25 DK DK421489A patent/DK421489A/da not_active Application Discontinuation
- 1989-08-25 HU HU894418A patent/HU204541B/hu not_active IP Right Cessation
- 1989-08-25 FI FI894007A patent/FI894007A/fi not_active Application Discontinuation
- 1989-08-25 NO NO89893431A patent/NO893431L/no unknown
Also Published As
Publication number | Publication date |
---|---|
JPH02111793A (ja) | 1990-04-24 |
FI894007A0 (fi) | 1989-08-25 |
DK421489D0 (da) | 1989-08-25 |
EP0355794A2 (en) | 1990-02-28 |
ES2061839T3 (es) | 1994-12-16 |
NO893431L (no) | 1990-02-27 |
ATE100466T1 (de) | 1994-02-15 |
AU4017689A (en) | 1990-03-01 |
EP0355794A3 (en) | 1991-01-23 |
AU620432B2 (en) | 1992-02-20 |
NZ230385A (en) | 1992-04-28 |
EP0355794B1 (en) | 1994-01-19 |
NO893431D0 (no) | 1989-08-25 |
PT91539B (pt) | 1995-05-04 |
HUT50486A (en) | 1990-02-28 |
KR900003203A (ko) | 1990-03-26 |
DK421489A (da) | 1990-02-27 |
ZA896374B (en) | 1990-05-30 |
HU204541B (en) | 1992-01-28 |
CN1040594A (zh) | 1990-03-21 |
IL91396A0 (en) | 1990-04-29 |
DE68912453T2 (de) | 1994-05-11 |
DE68912453D1 (de) | 1994-03-03 |
FI894007A (fi) | 1990-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT91539A (pt) | Processo para a preparacao de novos derivados peptidicos com accao antagonista do neuropeptido y | |
PT91538A (pt) | Processo para a preparacao de novos derivados peptidicos com accao agonista do neuropeptido y | |
PT94181A (pt) | Processo para a preparacao de heterociclos com 6 membros imidazo-condensados substituidos uteis como antagonistas de angiotensina ii | |
DK550685A (da) | Immunopotenserende midler samt deres anvendelse | |
DK604685D0 (da) | Vaskemiddel med blandede overfladeaktive midler og deres anvendelse | |
DK698088A (da) | Piperidinylforbindelser, deres anvendelse samt mellemprodukter til brug ved fremstillingen af disse | |
BR9002903A (pt) | Bucha para brocas com auto-aperto | |
FI901250A0 (fi) | Stabiloitu synteettinen massa-selluloosaseos | |
IT1182425B (it) | Materiali di rinforzo particolarmente per cuoio e relativo procedimento di fabbricazione | |
DK0741743T3 (da) | Cycliske neurokinin A-antagonister | |
ES292721Y (es) | Martillo de fondo para perforacion y sondeo | |
ATE41313T1 (de) | Steinduebelaehnliche ankervorrichtung. | |
BR8205306A (pt) | Composicao e processo para a fabricacao de um corpo ceramico sintetico com a aparencia de granito natural | |
BR6401941U (pt) | Mamadeiras com recipientes descartaveis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG3A | Patent granted, date of granting |
Effective date: 19941007 |
|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19960430 |